SG Americas Securities
HCAT icon

SG Americas Securities’s Health Catalyst HCAT Stock Holding History

SG Americas Securities’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Buy
+10,446
New +$15.1K ﹤0.01% 3265
2026
Q1 		– Sell
-12,260
Closed -$29K – 3422
2025
Q4 		$29K Sell
12,260
-1,990
-14% -$5.44K ﹤0.01% 3427
2025
Q3 		$41K Sell
14,250
-85
-0.6% -$291 ﹤0.01% 3219
2025
Q2 		$54K Sell
14,335
-66,490
-82% -$262K ﹤0.01% 2757
2025
Q1 		$366K Buy
80,825
+53,443
+195% +$283K ﹤0.01% 2038
2024
Q4 		$194K Buy
27,382
+4,874
+22% +$38.8K ﹤0.01% 2182
2024
Q3 		$183K Sell
22,508
-6,786
-23% -$49K ﹤0.01% 2573
2024
Q2 		$187K Buy
+29,294
New +$188K ﹤0.01% 2203
2024
Q1 		– Sell
-10,858
Closed -$101K – 3160
2023
Q4 		$101K Sell
10,858
-5,473
-34% -$44.7K ﹤0.01% 2760
2023
Q3 		$165K Sell
16,331
-119,306
-88% -$1.42M ﹤0.01% 2423
2023
Q2 		$1.7M Buy
135,637
+39,139
+41% +$466K 0.01% 814
2023
Q1 		$1.13M Sell
96,498
-18,671
-16% -$238K 0.01% 1052
2022
Q4 		$1.22M Buy
115,169
+49,872
+76% +$481K 0.01% 840
2022
Q3 		$633K Sell
65,297
-144,569
-69% -$1.91M 0.01% 1335
2022
Q2 		$3.04M Buy
209,866
+160,691
+327% +$2.74M 0.03% 518
2022
Q1 		$1.28M Sell
49,175
-337,323
-87% -$9.57M 0.01% 1239
2021
Q4 		$15.3M Buy
386,498
+84,164
+28% +$3.84M 0.08% 181
2021
Q3 		$15.1M Buy
302,334
+103,242
+52% +$5.63M 0.07% 173
2021
Q2 		$11.1M Buy
199,092
+134,304
+207% +$7.15M 0.05% 314
2021
Q1 		$3.03M Buy
64,788
+44,672
+222% +$2.16M 0.02% 772
2020
Q4 		$876K Buy
+20,116
New +$742K ﹤0.01% 1608
2020
Q3 		– Sell
-46,489
Closed -$1.36M – 3004
2020
Q2 		$1.36M Buy
46,489
+38,068
+452% +$1.05M 0.01% 1125
2020
Q1 		$220K Buy
+8,421
New +$257K ﹤0.01% 2438

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SG Americas Securities's HCAT Position: Q2 2026 in Review

SG Americas Securities opened a new position in Health Catalyst (HCAT) in Q2 2026: 10,446 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #3265 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in HCAT as recently as Q4 2025.

SG Americas Securities first reported a position in HCAT in Q1 2020 and has held it in 23 quarters since. The position peaked at $15.3M in Q4 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • SG Americas Securities held 10,446 shares of Health Catalyst worth $21K as of Q2 2026.
  • Health Catalyst was a new SG Americas Securities position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3265 holding.
  • SG Americas Securities first reported a position in Health Catalyst in Q1 2020 and has held it in 23 quarters since.
  • SG Americas Securities's Health Catalyst position peaked at $15.3M in Q4 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.